LC-DG and its PB, Sb, and probiotic combination LT could decrease TLR4, attenuate inflammation, improve colonic hypermotility, and prevent epithelial barrier impairment of IBS (24, 50, 52). Here, TLR4 is linked to irritable bowel syndrome.